ST-Segment Depression in Leads I and aVL: Artifactual or Pathophysiological Findings?
Document Type: Research Article
Affiliations: 1: Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China 2: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China 3: Department of Medicine, Kingston General Hospital, Queen’s University, Kingston, Ontario, Canada
Publication date: December 1, 2021
This article was made available online on April 7, 2021 as a Fast Track article with title: "ST-Segment Depression in Leads I and aVL: Artifactual or Pathophysiological Findings?".
Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. Cardiovascular Innovations and Applications is the official journal of the Great Wall International Congress of Cardiology (GW-ICC). It aims to continue the work of the GW-ICC by providing a global scientific communication platform for cardiologists that bridges East and West.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites